Skip to main content
Equibles
SPRY $4.02 -0.37%
SPRY logo
SPRY · ARS Pharmaceuticals, Inc.
Track SPRY — free

Use SPRY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SPRY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.02 -0.02 (-0.37%)
Russell 2000 member Rebalance outlook locked
Market Cap
$397.79M
Shares
99.45M
Volume · Oct 26 619.87K Avg daily vol (3M) 1.74M
All webcasts

Earnings call · FY2026 Q1

ARS Pharmaceuticals, Inc. (SPRY) Q1 2026 Earnings Call

Concluded May 15, 2026
May 15, 2026 0 turns
Period
FY2026 Q1
Runtime
—
Sources
2 artifacts
Revenue $22.68M +184.5% YoY
Diluted EPS -$0.61
Net income -$60.62M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed May 15, 2026 10-Q report Filed May 15, 2026

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$17.45M +124.8% YoY
Revenue Under Supply Agreements$2.74M
Revenue Under Collaboration Agreements$2.49M +1085.2% YoY
Full-screen source Call document

SPRY alerts

ARS Pharmaceuticals, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →